Allezoe Medical Holdings, Inc. (ALZM) is a holding company focused on acquiring the most high-quality and in demand medical products, solutions and services.

We believe it is possible to create value for shareholders as well as recipients of healthcare services at the same time, and we do so through acquisition and support of technologies that improve healthcare delivery and address the most urgent health issues facing the world today. Whether through diagnosis, treatment, or medical research itself, Allezoe is interested in companies that are making a striking difference in the healthcare system through technology and treatments for health issues that affect large populations.

Allezoe Medical Holdings is in the final stages of discussions to acquire a number of organizations including companies that:

• diagnosis and treatment of Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer. Human Papillomavirus (HPV) is the most common sexually transmitted infection. Approximately 20 million Americans are infected with HPV and it is expected that 5.5 million will contract the HPV through sexual contact each year.
• state-of-the-art implant technologies for spinal surgery
• do clinical trial research

You can read more about our companies here.

Under the guidance of Allezoe’s distinguished Board of Directors, the company continues to seek targeted opportunities for growth via strategic acquisitions in the medical device sector and related arenas.

please read our full disclaimer

Share this: